Genelux Corp has a consensus price target of $23 based on the ratings of 6 analysts. The high is $40 issued by Maxim Group on September 12, 2023. The low is $8 issued by Guggenheim on October 29, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 31, 2025, March 25, 2025, and November 15, 2024, respectively. With an average price target of $30 between HC Wainwright & Co., there's an implied 1119.51% upside for Genelux Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/31/2025 | Buy Now | 1119.51% | HC Wainwright & Co. | Emily Bodnar36% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
03/25/2025 | Buy Now | 1119.51% | HC Wainwright & Co. | Emily Bodnar36% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
11/15/2024 | Buy Now | 1119.51% | HC Wainwright & Co. | Emily Bodnar36% | $32 → $30 | Maintains | Buy | Get Alert |
10/29/2024 | Buy Now | 225.2% | Guggenheim | Kelsey Goodwin29% | → $8 | Initiates | → Buy | Get Alert |
08/27/2024 | Buy Now | 306.5% | Roth MKM | Benjamin Paluch23% | → $10 | Initiates | → Buy | Get Alert |
08/15/2024 | Buy Now | 1200.81% | HC Wainwright & Co. | Emily Bodnar36% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
06/03/2024 | Buy Now | 916.26% | Benchmark | Bruce Jackson38% | $25 → $25 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
05/31/2024 | Buy Now | 916.26% | Benchmark | Bruce Jackson38% | $30 → $25 | Maintains | Speculative Buy | Get Alert |
05/13/2024 | Buy Now | 1200.81% | HC Wainwright & Co. | Emily Bodnar36% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
04/03/2024 | Buy Now | 1119.51% | Benchmark | Bruce Jackson38% | $30 → $30 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
04/02/2024 | Buy Now | 1200.81% | HC Wainwright & Co. | Emily Bodnar36% | $35 → $32 | Maintains | Buy | Get Alert |
11/27/2023 | Buy Now | 1322.76% | HC Wainwright & Co. | Emily Bodnar36% | → $35 | Initiates | → Buy | Get Alert |
11/24/2023 | Buy Now | 1119.51% | Benchmark | Bruce Jackson38% | $38 → $30 | Maintains | Speculative Buy | Get Alert |
09/12/2023 | Buy Now | 1526.02% | Maxim Group | Jason McCarthy41% | → $40 | Initiates | → Buy | Get Alert |
06/09/2023 | Buy Now | 1444.72% | Benchmark | Bruce Jackson38% | $10 → $38 | Maintains | Speculative Buy | Get Alert |
05/18/2023 | Buy Now | 916.26% | Brookline Capital | Kemp Dolliver27% | → $25 | Initiates | → Hold | Get Alert |
02/15/2023 | Buy Now | 306.5% | Benchmark | Bruce Jackson38% | → $10 | Initiates | → Speculative Buy | Get Alert |
The latest price target for Genelux (NASDAQ:GNLX) was reported by HC Wainwright & Co. on March 31, 2025. The analyst firm set a price target for $30.00 expecting GNLX to rise to within 12 months (a possible 1119.51% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Genelux (NASDAQ:GNLX) was provided by HC Wainwright & Co., and Genelux reiterated their buy rating.
There is no last upgrade for Genelux
There is no last downgrade for Genelux.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Genelux, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Genelux was filed on March 31, 2025 so you should expect the next rating to be made available sometime around March 31, 2026.
While ratings are subjective and will change, the latest Genelux (GNLX) rating was a reiterated with a price target of $30.00 to $30.00. The current price Genelux (GNLX) is trading at is $2.46, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.